Women and COPD: Breaking Stigma, Challenging Misconceptions, and Finding Hope
In this episode of The Lung Health Champion, COPD Foundation CEO Jean Wright is joined by Dr. Dawn DeMeo, Dr. Niru Putcha, Phyllis DiLorenzo, and Valerie Chang for a conversation about women and COPD. Together, they examine the stigma surrounding COPD, challenges women face in receiving an accurate diagnosis, and the role of genetics, environmental exposures, and hormonal changes in lung health. Phyllis and Valerie share their experiences living with COPD, from managing daily activities to finding support and advocating for better care. The discussion also addresses financial burdens, representation in clinical trials, and emerging treatments such as biologics. The guests emphasize the importance of women's voices in research, health care, and advocacy while offering hope for people living with COPD.
Key Points From This Episode:
- (00:00:00) Highlights & Show intro
- (00:04:24) Breaking the stigma surrounding women and COPD
- (00:13:47) Why COPD is often overlooked or misdiagnosed in women
- (00:19:43) COPD risk factors beyond smoking
- (00:22:22) How genetics, hormones, and lung development affect women
- (00:25:22) Differences between asthma and COPD treatments
- (00:29:25) Daily challenges of living with COPD
- (00:32:25) Finding support through health care providers and community
- (00:33:48) Why representation matters in clinical trials
- (00:37:35) The financial burden of COPD treatment and caregiving
- (00:42:18) Women's leadership in COPD research and advocacy
- (00:47:34) Final Takeaways
Links:
The Lung Health Champion Podcast is brought to you by the COPD Foundation. Learn more at https://www.copdfoundation.org
- Sign up for COPD Foundation's Newsletter: https://copdf.co/faces
Learn more about COPD in women: https://www.healthywomen.org/condition/women-and-copd
Learn more about our guests:
- Dr. Jean Wright on LinkedIn: https://www.linkedin.com/in/jeanwrightmdmba
- Dr. Niru Putcha on LinkedIn: https://www.linkedin.com/in/nirupama-putcha-96171823/
Production and editing by The Podcast Consultant:
https://thepodcastconsultant.com
The podcast is provided by the COPD Foundation as an educational resource only and should not be considered as offering medical advice. This information should not be used as a substitute for a physician's professional judgment in providing advice, diagnosis, or treatment for any medical or health condition. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment before undertaking a new health care regimen. Do not disregard professional medical advice or delay in seeking it because of something you have heard on this podcast.
[Valerie Chang] (0:00 - 0:27)
And one of the doctors there said, yeah, you know, you did this to yourself. The doctor that was treating me said, excuse me, how did she do this to herself? We don't even know why she has this.
Please explain to all of us how this was something she did to herself. And he says, oh, she's not a smoker. I said, no, I've never smoked.
I've never even been around any long irritants. I said, oh, well, then I take that back. We have no idea why you have this.
[Jean Wright] (0:35 - 4:56)
Welcome to the Lung Health Champion podcast brought to you by the COPD Foundation. Each episode brings you practical tips, expert insights, and powerful lived experiences. You know what?
If you have lungs, you belong here, right? So let's all take a deep breath together and let's get started. I'm Jean Wright.
I'm the CEO of the COPD Foundation and your host for today's episode. And I'm so excited about this because not only do I know these people, I admire them. I consider them friends.
If I weren't older than all of them, I'd even consider them mentors because I learned from them every time I'm around them. So this month, as we recognize COPD Awareness Month, we're going to focus on an important part of the conversation that often is overlooked. It doesn't get nearly enough attention, and that's women and COPD.
So today, we're bringing together an incredible group of women who bring very different and equally important perspectives on this conversation. Let me just quickly introduce to you, Dr. Don DeMeo. Don is a professor at Harvard.
She's involved in our women and COPD efforts here at the Foundation. I asked her one day, how does she describe what she does to other people? And you told me, Don, you're a respiratory epidemiologist, right?
You're looking at the causes of respiratory diseases. She understands genetics on a level that's just like, you know, I'm just like, I don't even make any attempt to try to keep up on that. So everybody that field knows her and we're so appreciative of her knowledge.
Also on our screen is Phyllis DiLorenzo. Phyllis and I've known each other now. A number of years, she's a vicious, fierce patient advocate.
Don't let that size fool you. Behind that is a mighty lioness. And I was privileged to get to know her about four years ago when we started doing some work on the hill.
She even made me rehearse my script in front of her to make sure that I measured up to her standards. Phyllis has a background in social work and behavioral health. And so she thinks about this disease from a lot of different ways.
So Phyllis, thank you for joining us today. Along with her is Dr. Niro Puja. Niro is at Johns Hopkins.
She's a pulmonologist as well, like Dr. DeMeo. She also has our Medical and Scientific Advisory Committee, our MASAC. You know, we have a nickname for everything, an acronym for everything.
And so she has stepped up and taken that over this year. Niro has a lot of interest, including COPD. But she's got some interesting in-depth knowledge about financial toxicity, that the cost of care to the patient and to the system.
And then, last but not least, but farther offshore, is Valerie Chang. And Valerie joins us from Hawaii. It's a rough location.
I'm glad you took that one for all of us. You took a bullet by going to Hawaii for us. Valerie's a lawyer by background.
She heads a patient advocacy group there in Hawaii. Hi, COPD. Have you ever gotten an email from her?
And she's a board member and always a trusted voice who brings the voice of the patient to so many different episodes and activities and patient panels. So again, thank you all for joining us today. So let's get started.
I want to start with kind of a basic misconception. For years, I could walk into a group and say, close your eyes and let me say the word COPD and what kind of persona, what face comes to mind. And often it's an older person, a male, and smoking.
And it's very hard to get people to move behind the look of the Marlboro man to something that reflects the faces and the voices that are in the room today. So Phyllis, let me start with you. I know both in your career you've dealt with patients who've had stigma for a variety of reasons.
How does stigma affect COPD? And how do you think COPD is stigmatized?
[Phyliss Dilorenzo] (4:56 - 5:50)
It's terribly stigmatized. I remember when I was first diagnosed and I used quotes because I was diagnosed by primary care physician in absence of a PFT. It was by X-ray when I had a bout of pneumonia.
And he just said, you have emphysema, but of course you should expect that because you're a smoker. And I said, well, I'm an ex-smoker, yes. And he said, I don't know why you people do this to your lungs.
And I said, well, I'd like to tell you, you know, but I don't have the time to school you in behavioral therapy.
[Jean Wright] (5:52 - 5:55)
And you would be the person to school at Phyllis.
[Phyliss Dilorenzo] (5:55 - 6:26)
And subsequently I found a new primary care. But yes, the stigma is always there. It's lessened, I believe, over the past year or so, from what I've been experiencing and hearing from other patients.
But there's still a lot to overcome. It's still seen as a smoker's disease primarily.
[Jean Wright] (6:27 - 6:45)
Yeah. And boy, we have some science that we'll cover in a different episode about how the roots of COPD start in childhood. And it's not just a smoker's disease.
Do you think that stigma keeps patients, especially women, from seeking out medical advice?
[Phyliss Dilorenzo] (6:45 - 7:41)
Absolutely. I think many women still feel that way. They blame themselves and they feel terribly shamed.
If anyone thinks that they are a smoker and therefore this is why they have COPD, the shame can be overwhelming for them. I know my mother, who had COPD, but subsequently developed lung cancer, I believe her shame and guilt played a big role in her not accessing a lot of treatment that was available. So she sort of said, well, I did this to myself, sort of like I made my bed, so now I'll lie in it.
And it was a terrible thing to watch.
[Jean Wright] (7:42 - 8:15)
Right. It is so tough. And you think, oh, stigma is just in your head, but it so impacts people's decision-making and then the action they'll take in terms of getting care or sticking with care.
Now, Val, you've got a different story because smoking wasn't part of your cause of COPD, but it was still hard to diagnose if I'm not mistaken, right? So tell me about that journey. I've seen 13 lung doctors.
How many lung doctors? 13.
[Valerie Chang] (8:16 - 12:01)
13, the lucky 13, right? And I have two that I still have, so I'm good. I was 42 when I was diagnosed.
It was out of the blue. I went because I couldn't keep up with my kids and my husband said I looked terrible when we were hiking on this hike in a national park. He said, stay there.
I'm going to move the car because you look really bad. And so he picked me up and he says, you got to go to the doctor and find out what's going on because we're going to go on a longer trip and we want to make sure you're okay. So we went to my internist, Nini goes, okay, you had a complete physical.
You're in great shape. Congratulations. I said, no, we have to find out why I'm breathless and why I'm waking up at night breathless.
So he says, well, it's a waste of time. I will send you to pulmonary function lab, but it's a waste of time and money. You set me and the tech kept saying, are you okay?
Are you okay? You're really doing bad. That's bad when they look worried, right?
Yeah, this is normal. He said, you got to go back to your doctor, like right away. I said, okay.
Thank you. So I went back and says, yeah, you know, your lung function is really, really bad. I'm going to send you to some lung specialists and they'll make you better.
So the first one school did me for not getting care sooner and said it was all my fault that I had not gotten care sooner. And I had done irreparable damage to myself and I had really, really bad lungs. And then he gave me a test and he went on vacation.
So I kept calling his office to try to get the results of the test. And they said, oh, yeah, the test was negative and he's on vacation. So we can't talk to you.
I said, okay, thank you. So I found the next doctor and he said, oh, I'll make you better. And he gave me a course of treatment that kept making me worse.
And then he says, well, I'll see you in the ER in six months or a year. So I went to back to my internist. He says, you know, you should go to Denver, National Jewish.
They'll help you. I said, can I try one more time to find a local doctor because I don't really want to fly 5,000 miles to go get care. And he said, okay, you can try again if you want.
And I tried again and got worse. And I finally said, well, I guess I better go because I keep getting worse with each doctor and each treatment. And so I went to Denver, National Jewish.
And they said, you know, we don't understand your course of care up to now, but we will help you. And one of the doctors there said, yeah, you know, you did this to yourself. And the doctor that was treating me said, excuse me, how did she do this to herself?
We don't even know why she has this. So please explain to all of us how this was something she did to herself. And he says, oh, she's not a smoker.
I said, no, I've never smoked. I've never even been around any long irritants. I said, oh, well, then I take that back.
We have no idea why you have this. Anyway, based on those experiences when I started my nonprofit, I always say we also include people with chronic asthma because chronic asthma seems a little less stigmatizing and a little more inviting to some patients. So they might come to our group, even though they would not come if they thought it was COPD because they always think that's a death sentence.
Anyway.
[Jean Wright] (12:01 - 12:41)
Oh, my goodness. Oh, wow. This story is getting enriched from these personal experiences already.
Let me ask you one more question. Then we'll switch to Dr. Pooja. How does it feel, Val, to have a disease that people still can't wrap physicians, still can't wrap their arm around their hands around and tell you you have X, you need Y and Z will be the outcome.
Most of us right now, we like that. Oh, you have a risk for coronary artery disease. You need to be on a statin.
If you're not on a statin, here's what will happen. But the path for you is not clear. Right?
[Valerie Chang] (12:41 - 13:34)
It was very confusing because they told me in 2000 to get my affairs in order because I would not live very long and I need a lung transplant very soon. My kids didn't believe it. They said, no, mom's way too healthy.
That's the doctors don't know what they're talking about. And 26 years later, I'm still about where I was then. Wow.
I would say there's a lot of unknowns. And when I got diagnosed, I went to the medical library and read everything I could find that was about COPD. And all of them were very dire that if you have really low lung function, you really aren't supposed to live very long.
But that was then. And I think things for whatever reason seem to have changed. And people do live a lot longer than we're projected to.
[Jean Wright] (13:35 - 13:36)
And we're grateful for that.
[Valerie Chang] (13:36 - 13:44)
Thank goodness. Your doctor, the male and doctor Puccia. I mean, I think that they've had a good role in it.
[Jean Wright] (13:44 - 14:04)
We got the queens of the field here, right? So what does it feel like to be a doc and seeing patients in your office? Because I know you're an esteemed researcher, but I also know that you see patients.
How do these stories either sound the same as stories you've heard? How do they sound different? What's it like from your side of the exam table?
[Niru Putcha] (14:04 - 18:16)
Yeah, I think, you know, it's really familiar to hear Phyllis and Val's stories just as far as the challenges with getting a diagnosis and how those challenges are really, you know, unique and potentially specific to them as women who have the disease. The idea that there's under-diagnosis of women with COPD is certainly not something that anyone would dispute. It's often under-diagnosed in women, especially early on.
Because the symptoms are often subtle and then mistaken for other comorbid chronic diseases that share symptoms or can heighten symptoms like heart disease and anemia. And then even often misdiagnosed as anxiety. And so I think there's a really common thread here about sort of being misdiagnosed or even misrepresented, right, as having done this to oneself.
But particularly with the under-diagnosis, there's delays often for women in getting care. And I think as Val noted, because of the challenges, you know, to pinning down a diagnosis for her, obviously delays in getting what she needed and getting the right tests, getting the right referrals, can push the diagnosis and to later in the disease. And that matters because, you know, the earlier diagnosis means getting treated earlier, getting some to manage earlier.
So, yeah, doesn't mean that women can't have classic symptoms of COPD. It certainly happens a lot where women present classically. But there are some differences and I think some reasons behind that.
You know, there's research showing that women with COPD report shortness of breath earlier or more intensely and out of proportion, so to speak, to the level of lung function decline. And so that doesn't help, you know, the process of getting the right treatment and getting the right diagnosis and getting attention for your symptoms. I do think women tend to normalize symptoms too and, you know, chalk that up to stress, deconditioning, menopause, getting older.
This is a confusing time because, you know, getting the diagnosis of CPD, I suppose, you know, Dr. Dameo will get to this in a bit. But, you know, getting the diagnosis in the same time of life when someone is going through those major life hormonal changes can really cloud the picture with symptoms too. And so I think those are really, you know, common challenges with making the diagnosis.
The other thing that, you know, Val's case really does highlight too is that non-smoking COPD, putting quotes around that, right? But COPD that has arisen from risk factors that are not like having been a smoker. That is obviously, you know, a little bit more challenging, particularly in the U.S. I think there's probably a lot more mindfulness of that in low and middle income countries these days. But certainly in the U.S. it's, we're less mindful and we don't look out as much for these cases. And so it really makes it hard to pin down the right diagnosis in the end as it just so happened. And it's not coincidental that non-smoking COPD is more common in women.
And so that is like an extra challenge for patients like Val and others. And so I think those are all challenges I think I see in the clinic. And I know that, you know, our friends here on the podcast have experienced.
And then I do think, like I said, the symptoms with the overlap in other diseases, particularly things like anxiety and stress, there's this over attribution of the symptoms of COPD breathlessness, shortness of breath, chest tightness to anxiety. And so this tendency to minimize that experience and then attribute them to a real disease that has treatments. Not that, you know, anxiety is not a real disease, but it is distinct and treated differently.
And so we need to recognize lung disease for what it is.
[Jean Wright] (18:16 - 20:07)
Right. And you both are pulmonologists. So for somebody to come to you, they've already been seen by somebody else.
You know, it would be interesting if we had a primary care doc here on the call because I know I was hosting a panel about a year ago, and there was a primary care PA who was on the panel, and he said the most frustrating symptom for him to work up is fatigue because it can be, right? Not being in shape. Right.
Let's just start with, you know, the obvious. It can be menopause. It can be, and you start listing all the things it can be.
And I wonder if you're on that side of the exam table and if you're looking at a man and you're looking at a woman, are you going through those, we call it differential diagnosis? Are you going through that list differently? You know, are they thinking about cardiovascular disease, heart failure, higher up?
Are they thinking about menopause with women higher up? I don't know, but we do know there's maybe not intended, but certainly unconscious bias when women come into an exam room and like Val, like Phyllis, their disease did not jump out, right? And, you know, get the attention of their provider right away.
What we've got all of you here on Hollywood Squares, let's kind of do a round table. Other than smoking, what are some risk factors for women? Everybody can name one, all right?
Tell me when you got one. Low birth weight? Birth weight, low birth weight.
So if you were a preemie, right? If you were a preemie, you know, that's my past work and I'm so grateful for all those preemies, but they are a set up. Val, what you got?
[Valerie Chang] (20:08 - 20:18)
Occupational, if you were a baker or someone around a lot of dust or countermakers, they get all kinds of respiratory problems.
[Jean Wright] (20:18 - 20:38)
Yeah, so occupational exposure. I think of it every time I go to get my nails done, right? Because there's this fog of smoke in there, and the technicians may or may not be wearing a mask, and Dawn's looking at me with that all-knowing eye like Jane.
How could you do that? So Dawn, what other things might put women at risk? Yeah, I would say genetics.
[Dr. Dawn Demeo] (20:39 - 21:09)
Genetics. You know, and I think this is a really critical issue because we know there are proven genetic causes of COPD, as well as family history playing a role. So knowing your family history and thinking about genetics is really important, especially, again, given Val's history of never having smoked.
And I think I just want to add, this is the infuriating thing. Everyone says, get rid of smoking, we'll get rid of COPD. And that is reductionistic.
That is not true. So genetics.
[Jean Wright] (21:10 - 21:58)
Genetics. And most of us in the field, we think of Alpha-1 because that's been known for quite some time. You've been involved in a huge project called the COPD gene project where you followed 10,000 patients, people who have known COPD, looking at all of their genetics.
And I keep hoping that you're going to find the silver bullet, right? Something that's a lock and key model. I don't think it's quite that easy for what you guys have shared.
But if not the genetics, certainly what happens to you in childhood. So we know outdoor air pollution. We know where people work.
We know for veterans is burn pits. We know for firemen, fire women, first responders is not only the smoke, but it's those terrible toxins in whatever's being burned at the same time.
[Dr. Dawn Demeo] (21:59 - 22:19)
And I'd like to add just one other thing. And we don't really have all the evidence yet, but we can't forget vaping because anything inhaled is potentially injurious. So Jean, just adding to your litany of environmental exposures or other inhaled toxins.
We cannot forget vaping and the risk to adolescent and young women.
[Jean Wright] (22:19 - 22:45)
So let's go back to serious science there, Dawn. Talk to us about women's lungs. Dawn, you've really educated me and made me realize, you know, it's more than what we used to refer to as bikini medicine.
Women's health goes beyond the bikini zone, right? It impacts every single cell that we have. It's also more than hormones.
Kind of wax eloquent for us a little bit about women, genetics, COPD.
[Dr. Dawn Demeo] (22:46 - 25:22)
What we've learned so far is that when we think about what are the risk factors, we know that for every cigarette smoked, women are more susceptible. With regard to COPD, women may never have smoked and we covered some of this. And the question is why, you know, when we look at some of the research that emerged from COPD gene, we know that when people are diagnosed with COPD before age 53, so even before menopause is fully in action here, they tend to be women with advanced severe COPD with advanced emphysema.
And so we know that women may present earlier. They may have less exposure history. And the question is why?
Is it because women have smaller lungs? Well, they do, but we don't believe that's the only reason. Is it because there's some genetic variation?
Well, if we think of our genetic alphabets, men and women are mostly the same as men, except we have these other chromosomes, some people call them sex chromosomes. They're called allosomes, that may hold the secret to some of female versus male-specific susceptibility differences. So we have research going on in that space.
Childhood, you brought this up. If we think of what we understand about lung development and some of the research we've done in COPD, developmental differences in lung anatomy may be something that pretends sex differences later in life and differences between men and women with COPD. And so there's a whole host of bringing this all together in a life course.
And what happens across the life course is variation in hormones in the context of all these exposures. And so we'll talk more about this later. But at these critical windows of lung development, children go through puberty, and then they may become pregnant, and then they may go through menopause or andropause, the change that males experience.
So it's very complicated. It's not one answer here of what we may understand separating COPD and women versus men. But I think one thing is true, that we need to think about COPD as a diagnosis in women, because women tend to be misdiagnosed as having asthma.
And I think it doesn't mean it's not important to include people with persistent asthma in our conversation, but we have to remember not all shortness of breath and not all wheezing, and women is asthma. So I think raising awareness that COPD happens in women, and that the underlying ideologies may be differentially contributory, is really important.
[Jean Wright] (25:23 - 25:38)
Yeah. And for the two doctors here, help the laypeople that are listening to this understand. Are the treatments the same for asthma and COPD?
Are they different? Do they overlap? I know I'm asking you a loaded question.
Niru, you go first.
[Niru Putcha] (25:39 - 26:31)
Yeah, it is a loaded question because there's like a little bit of flux in the field, but I think we'd all agree that there's a ton of overlap. And I know this because I send those COPD foundation inhaler teaching videos to a lot of my asthma patients too. I love those videos.
Thank you, Jean. So tons of overlap, but the mainstay of treatment for asthma is the inhaled steroid, whereas in COPD, the key difference is that that's sort of an add-on for a subset of patients. And so we think that dilation of the airways is the most important thing in COPD, whereas in asthma, that reduction of inflammation with the inhaled steroid is the most important anchor, the biggest piece of the treatment that's effective.
So key differences, but lots of overlap, and that's evolving too. Right.
[Jean Wright] (26:31 - 26:43)
And that's why we need informed physicians and providers who really can differentiate between the two. Don, other thoughts on that about why you really need that crisp, accurate diagnosis?
[Dr. Dawn Demeo] (26:44 - 27:57)
I think part of it is relating to, you know, from what I think about in terms of sex differences, is we really want to meet the person where they are. If we talk about precision medicine, which is the goal of, you know, the 21st century, to treat each person as an individual, we really want to have some sense of what is their underlying lung looking like, how much inflammation, how much sputum, you know, how much symptomatology. I mean, there's a whole new class of medications that we're all excited about for asthma in COPD called biologics.
And no one has really thought about the sex differences in response or how we may differentially manage those by sex in COPD. This is a whole open area that's really important as we think about some of the underlying drivers in men and women. And so, as Dr. Putra points out, you know, there is some overlap, there is some differences, but as we move from research to the bedside, getting to precision means maybe not giving the exact label, but really understanding what's happening in the lung and what are the individual specific drivers, regardless of whether it's a male or a female. And so, I think as we learn more about disease etiology, whether it's asthma or COPD, we'll have a better answer. Next podcast.
[Jean Wright] (27:58 - 28:30)
All right, all right. I love that. You're teasing it.
It tees it out of us. Yeah, there's always a hook, right? Stay tuned for the next episode.
I do know that when we talk about women in COPD, again, with the lay public, they almost always want to make it simple. I use the phrase reductionistic earlier. That's too big of a word for somebody from Detroit.
But we say simple, right? We want to make it simple. Like, it must be hormones, yes or no.
But what I'm hearing from you, it ain't all that simple, right? It all ain't all that simple.
[Dr. Dawn Demeo] (28:30 - 29:20)
No, it's not one thing. And I think what we don't have time for in the clinic is to take a full history back to childhood. And I think Val, when we meet people like yourself who say, I've never smoked, we need to think of the environment.
You know, in Hawaii, a lot of children are exposed to VOG or volcanic ash. That's an important climate-related or environmental contributor. As we think about the other growing concerns around climate and volcanoes and natural disasters, wildfires, we really need to think more broadly.
We need to get out of this box of one thing, one size fits all, and trying to understand the diagnosis and really expand the science to meet that reality, that to better treat COPD, to prevent, to cure, we really need to be inclusive in how we think about risk factors.
[Jean Wright] (29:21 - 29:48)
All right, let's talk about real life. And we'll kind of move to this next segment about how do people live with this disease? Villas, let's start with you.
Talk to me about some day-to-day things that because you have COPD, you have to think about your life differently, right? You have to think about me about access to an apartment. And if I'm not mistaken, you moved because just getting into the apartment, right, was a challenge.
[Phyliss Dilorenzo] (29:49 - 31:00)
The apartment I was in was really not a very conducive to anyone with respiratory illness for a lot of reasons. It was very, it trapped the humidity. It was a basement apartment.
It trapped the humidity. There was a lot of dust and everything. And as someone with COPD, who also has a bit of OCD, it's very hard to say, well, I can't keep up with cleaning the way I like to because my disease and the fatigue holds me back.
So that makes living with COPD difficult because you start to blame yourself. You start to get depressed because you're unable to do all the things that you used to do in a manner that satisfied you.
[Jean Wright] (31:01 - 31:07)
Val, how does having a disease impact your quality of life and what you and Blan want to do?
[Valerie Chang] (31:07 - 32:22)
It really makes it much more deliberative. You have to plan spontaneity is kind of out the window. My brother is two years younger than me and he keeps inviting me to go on trips with him.
And I said, you know, I'd love to be able to do stuff with you, but I need a much longer runway. We need to be able to plan. I have to figure out what altitude every place we want to visit is and how much oxygen I will need at each altitude.
And I will have to see how I will get the oxygen. When we went to Scandinavia, I had to bring two oxygen machines, one that was continuous flow and the other one I wore for the airplane. And it's not for the faint of heart, but it can be done.
So you just need to do a lot more planning if you want to have as active a life as you can. And I've crossed off a lot of really high altitude places off my list anymore because it's just getting harder and harder to deal with 5 and 10,000 feet elevations.
[Jean Wright] (32:23 - 32:30)
Now, where do you go for support and for people that get you and understand you and, you know, can you encourage you?
[Valerie Chang] (32:30 - 33:38)
Well, I've been very fortunate because I have a very good relationship with my two lung doctors. One is in Honolulu because it's always good to have a local lung doctor. And one is that UCSF and I met her because she was one of the speakers at one of the COPD Foundations conferences that they had.
And she and I spent until midnight talking and I said, you know, if I ever need a doctor in San Francisco, can I go to you in case your mentor that I was referred to is unable to see me for any reason. And she's become my second lung doctor and it's been very helpful because sometimes I can reach her more easily than my Hawaii lung doctor and sometimes I can reach him more easily. So I think they share the load and then they also were both able to coordinate to help me figure out which biologic would help me not have so many exacerbations.
I used to have one to six a year and I started the biologics. I haven't had any.
[Jean Wright] (33:38 - 33:50)
So that is so remarkable. I love it.
[Valerie Chang] (33:50 - 34:03)
They don't test a lot of these things on people like me because I'm Asian and I've never smoked. And so people like me are not in clinical trials. So I feel like I'm a clinical trial of one.
[Jean Wright] (34:03 - 35:11)
Let's highlight that point. And thank you to our now, our now who have pulled our script together. Because this is a really important point, you know, new medications, new treatments, new devices are tested, you know, they're tested for safety and outcome.
But the most important test, you know, comes down to patients. And if you've never been in a clinical trial, you don't realize that they're asking you questions about, you know, have you had a pulmonary function test? Have you ever been tested for alpha one, the genetic disease?
Did you smoke? Baba? So if you're a val and she puts down, she never smoked.
There's a whole set of clinical trials that she's not in, right? And because you're blessed to be Asian, remember my kids are Asian, so I claim it as well, right? I don't know if I adopted them or they adopted me, but I claim to be an Asian.
Our people are not that well represented. And so a drug or a device or trial that may have really worked, right? And Caucasians or Europeans may or may not work the same way.
[Dr. Dawn Demeo] (35:11 - 35:51)
But Jean, I think you're highlighting a very important issue because historically women have been excluded or of the underrepresented group and clinical trials. And we've talked about this for years in pulmonary where in some clinical trials, this is still the case, including for newer medications where the representation of women is not 50, 50, and the representation of women of color or any person of color. So I think we need to really continue to do better in powering clinical trials for some of these basic differences, which will get us to a real precision medicine capacity.
[Jean Wright] (35:51 - 35:55)
Didn't the NIH require that there be more women?
[Dr. Dawn Demeo] (35:55 - 36:14)
There was a mandate for inclusion of women, but we still can look around in many examples where women remain underrepresented in terms of trials. And that trials are not powered to identify sex differences. So we just need to do better, do more.
[Jean Wright] (36:15 - 36:23)
Now, and that's a little phrase you put in there. And the second bell, powered. What does that mean?
Did you power a study for something?
[Dr. Dawn Demeo] (36:24 - 36:40)
It means that when you do the statistics, you have a better than chance possibility of finding what you're looking for. I mean, that's a very basic definition, but it means you have the numbers to find the size of the effect you're looking for.
[Jean Wright] (36:40 - 36:53)
Right. So if you had 100 people in a study, 97 were men and three were women, there wouldn't be enough women in there, right, to really be able to say, yes, and women do this and men do that. Right.
[Dr. Dawn Demeo] (36:53 - 36:53)
That's a great example.
[Jean Wright] (36:54 - 37:03)
Yes. Thank you. Thank you.
I might be a scientist at some point in the future. If there's an opening, I'm just messing with you. All right.
Val, were you going to say something? I thought I saw a handle them.
[Valerie Chang] (37:03 - 37:24)
Yeah. The other thing that they don't usually allow is people that have asthma to be included in COPD studies. And many of us, like me, have asthma and COPDs.
So it's good point. It's really hard. And they always say, you know, your side effects are so unusual.
And I'm like, yeah, because you never test things in people like me.
[Jean Wright] (37:25 - 37:59)
Wow. Wow, wow, wow. I'm hoping this episode gets picked up by a lot of different advocacy groups and industry partners, because I think there's a lot, a lot to think of.
Let's talk to another kind of quality of life issue. And that's this whole financial toxicity. I never really knew about that phrase to this last year.
And those of you at Johns Hopkins, I think you're using it quite a bit. Explain that to us. And what's the cost of this disease to patients, to systems, to our country?
[Niru Putcha] (38:00 - 42:18)
This is, you know, obviously a very important topic. All of the chronic diseases and the people treating those diseases and the health systems should be thinking about it, because, and of course, the patients are already thinking about it. Right.
And have experienced it. But I'm fortunate to work with some colleagues at Hopkins who've been really digging into it. And so I guess this concept of financial toxicity, it sort of combines the idea of that like actual material burden.
Like, here's how much I pay for X, Y, and D with the stress that it causes that can have implications for your actual, you know, how the disease does, right, how you do with that disease, because stress is actually. Something that has real health implications. So it's sort of a concept that combines the both the actual material burden with the stress and its downstream implications.
And I think the chronic disease where this has been studied the best is cancer. And so there's been a lot more work around what are the implications of that toxicity on health in patients with cancer. And as I mentioned, one of my colleagues at Hopkins really was trying to look into this.
And this is hard to capture with like our traditional types of research studies. So this, this group is quite brilliant. They did what we call qualitative research.
So it's essentially interview based research to be able to sort of capture the actual patient stories around the toxicity, the financial burdens and how that impacts their lives. And they were, they showed in an article published in the Journal of the COPD Foundation that it's very common, you know, and Val and Phyllis can tell you up, duh, right? But it's very common, financial toxicity in COPD.
And it really impacts people's ability to manage their disease, their management of their household, and their wellbeing overall. And why does this happen in COPD? And I can tell you what my patients tell me and Val and Phyllis I'm sure will say, yep, yep, yep.
Like this is so, so many reasons. Inhalers are crazy expensive. Sometimes your provider who you see in clinic doesn't even have visibility on which inhaler they should be prescribing, right?
And so right then and there they're going to give you a script and you're going to go to the pharmacy and they're like, oh, that'll be $400. And where is that coming from? So inhalers are expensive, oxygen expensive.
It's expensive to go to pulmonary rehab sometimes. It's expensive to get there because of transportation costs. It's logistically challenging.
And why is this important for women specifically since that sort of are a theme for today? I think most of us can agree that women are also the higher burden of caregiving in the home is placed on women. And so if you think about managing a household, sometimes my patients who are female are managing all the generations of the household.
They have a very advanced-age parent that they're caring for. They have adult children and grandchildren that they're helping to care for both physically and financially. So you can imagine how much stress financially that is in addition to being able to deal with all of the costs.
And then all of that is at some kind of crazy, unmanageable study state and then you go into the hospital. And what happens to financially as a result of hospitalization is if you are still working, they're missed wages and there's cost of the hospitalization itself and afterwards. So it's not surprising that women experience this more acutely than men.
And how does this look? This looks like some of our patients come and are stretching their inhalers longer than they should. So I'm not using all the doses so I can get this to last a little bit longer.
So that's really underdosing and not getting the real effect of the drug. Patients who have to make hard choices about what they can afford. Sorry, I just cannot do rehab.
It's a very highly effective intervention. But if you can't get there because you don't have transportation, if you don't have the money for a Lyft or an Uber or whatever it takes, it's not happening. And that has impacts for health.
So I think that caregiving is part of that financial toxicity particularly for women.
[Jean Wright] (42:19 - 42:58)
Let's kind of wrap up and turn the corner talking about women as leaders in this field. Many of you speak out in different locations and places on behalf of this. I know Don, you've got something coming up in the spring around women and lung disease.
Talk to me about, because I've watched you go through this epiphysis. No, that's not their epiphany. Epiphysis is the end of your long bone, right?
Epiphany is when you get the light. So the light has come on and you said, I really want to become a voice for change in this. Tell me about how you've gone from thinking as a scientist to now thinking as an advocate.
[Dr. Dawn Demeo] (42:58 - 43:37)
So I've been thinking about women in COPD for more than two decades. And I think now we're at the moment where we really can support the research, shout out to the National Institute of Health, who's been very visionary in supporting COPD gene as well as the top med program to help generate genetic and genomic data so we can move the precision science forward. And I just think it's taken getting to this moment.
Part of the dialogue COPD is not a part of is the menopause moment. Dr. Wright and I are going to change that next week, where we've been talking about ways.
[Jean Wright] (43:37 - 43:38)
It'll happen in one week.
[Dr. Dawn Demeo] (43:38 - 45:13)
Stay tuned. And one week to really put the lung in the conversation of women at midlife. And so it's the slowest march forward, but it's really been a journey where the science is now meeting up with the patient needs and the voice that the patient who's a woman can find through research has really brought me together working with the foundation and really making sure the messaging that we put forth reaches everyone, male, female, men, women, everyone.
And I just want to say that the way we share science with the public needs to be intentional, thoughtful, meaningful, and relevant to every patient, you know, Valerie, you use the term people like me, patients like me. The research has to be for every patient to really get to the point where, with COPD, there is no this patient, that patient, male, female patient, everyone's being treated as an individual. And so we're really excited with the work we're doing with the foundation, the work we're doing with the NIH to really move this compass needle where women at midlife are really being well served.
So I think that's really what brings me to taking my career in science and medicine and really continuing to be an advocate and finding mentors in the advocacy space like Phyllis and Val and Jean. It really makes everything that much more meaningful. So that's what brings me to the table.
[Jean Wright] (45:14 - 45:30)
Phyllis, I saw you advocating in Washington where if I've been your doctor, I would have let you go, right? I would have been too worried about you, but you were there plugging ahead. Tell me about women as advocates.
Why is it so important for you to go to Washington?
[Phyliss Dilorenzo] (45:30 - 46:16)
It's important for women to bring their voice, especially to the representatives. A lot of times on Washington, it seems like there's an old boys club. So to meet with women who are patients and saying, yes, I have this disease, but here's what I want you to know.
Here's what we need, all of us, all of the COPD patients. Here's what I need you to do. And yes, you need to do something because we pay your salary.
[Jean Wright] (46:17 - 46:35)
You can tell she's a tiger on the hill, right? Nayru, why is it important to bring your voice as a female physician, right, to the table? Why are you interested in, you know, I know what all you're working on.
You wouldn't have to do this. You wouldn't even have to take this hour out. Why is this so important to you?
[Niru Putcha] (46:36 - 47:33)
I mean, I think, as you said, people need to see people who look like them or, and everybody looks so different, right? And so women patients need to see women at the highest levels or on every level, right? We need leadership.
We need people willing to talk. We need people willing to destigmatize COPD and smoking, you know, and I think women's voices in all of those spaces are important. And so I think women need to be active in science, need to take care of patients, and need to be on the hill like Phyllis and so on all levels.
Mentorship and strong leadership, and we really want to follow that and see more people from all kinds of backgrounds so that patients with COPD can see someone who looks like them.
[Jean Wright] (47:34 - 47:40)
Yeah, all right, Val, no pressure, but bring us home. You've got three on base, all right? You're the walk-off home run.
[Valerie Chang] (47:40 - 49:24)
One thing that we forgot to mention, or probably just everyone knows, because when you can't breathe, sometimes you have to retire early or cut back on your salary early, and you can't aspire as much as you'd like, that adds to the financial toxicity and it also reduces the household income. And I think that that's a point that is often overlooked also. But I think the more voices they see and the more people they see, they realize it's the aunt, it's the neighbor, it's the everybody.
And this disease affects so many people, and you don't have to look sick. I mean, everyone says, but you look great. You don't have to look sick, but you can still have a hard time breathing, and they're like, but you travel.
I said, yes, and you can travel if you have the right supports, and I'm fortunate to have those, but many people don't. So I think we try to give hope, and we also try to tell people what is possible, because everyone assumes you got to get your affairs in order, your life is over, and I'm here 26 years later to say, no, your life is not over. You really can still do a lot, contribute a lot to the world.
I was a part-time judge after I was diagnosed with COPD. I did a lot more, and now I started a nonprofit. So, you know, it doesn't mean we need to all plan our funerals.
I mean, it's a nice thing to do to help your loved ones, but we still have a lot more to do.
[Jean Wright] (49:25 - 49:30)
We might take that line out of this show, or I just, I go to that.
[Dr. Dawn Demeo] (49:30 - 49:59)
Jean, the one thing I'll just add is that women all over the world are waiting to exhale. They are waiting to find this voice. They're waiting for this moment where COPD is recognized as a disease that impacts women differently, but needs to be part of the conversation.
And so thank you so much for championing this cause and for everyone on this podcast, but we just need to keep on going and keep the conversation moving the compass need also.
[Valerie Chang] (49:59 - 50:08)
Thank you.
[Jean Wright] (50:08 - 50:45)
Absolutely. COPD does not discriminate, right? So get in on the conversation.
If this episode resonated with you, we hope that you will share it with somebody that you know. Surely there's somebody in your field of influence that could benefit from this. So share it, share it, share it, get the word out.
It's so important for women to understand this could be them. It doesn't have to be a smoker's disease anymore. It doesn't have to be a male-only disease anymore.
It could be them. And thank you for listening to the Lung Health Champion podcast.
[Disclaimer] (50:48 - 51:45)
Thanks for listening to Lung Health Champion. If today's episode helped you breathe a little easier, be sure to leave us a rating or review on Spotify or Apple Podcasts. It'll help the show reach other potential lung health champs.
If you have any questions about today's episode or have suggestions for topics you'd like covered on the show, feel free to reach out to us via email at share@COPDfoundation.org. For more insights on lung health, follow us on Instagram and Facebook by clicking the links in the show notes. For more info on what we do at the COPD Foundation, visit our website at COPDfoundation.org.
And don't forget to subscribe or follow the show on your favorite podcast app to make sure you never miss an episode as we continue to empower everyone to breathe easy. This podcast is for educational purposes only and is not a substitute for medical advice. Always consult your health care provider with questions about your care.
Apple Podcasts
Spotify
Amazon Music
YouTube 
